Search
Evifacotrep
go.drugbank.com/drugs/DB21510InvestigationalEvifacotrep has a monoisotopic molecular weight of 441.06 Da. … Evifacotrep is a small molecule drug. The usage of the INN stem '-cotrep' in the name indicates that Evifacotrep is a transient receptor potential canonical channel 5 (TRPC5) antagonist.
Zosurabalpin
go.drugbank.com/drugs/DB21539InvestigationalZosurabalpin is a small molecule drug. … Zosurabalpin has a monoisotopic molecular weight of 790.36 Da.
Abimtrelvir
go.drugbank.com/drugs/DB21596ExperimentalAbimtrelvir is a small molecule drug. The usage of the INN stem '-trelvir' in the name indicates that Abimtrelvir is a antiviral 3CL protease inhibitor. … Abimtrelvir has a monoisotopic molecular weight of 527.11 Da.
Bocodepsin
go.drugbank.com/drugs/DB21622ExperimentalBocodepsin is a small molecule drug. Bocodepsin has a monoisotopic molecular weight of 581.23 Da.
Nispomeben
go.drugbank.com/drugs/DB21672ExperimentalNispomeben is a small molecule drug. Nispomeben has a monoisotopic molecular weight of 357.19 Da.
Zapomeran
go.drugbank.com/drugs/DB21761ApprovedZapomeran, marketed under the brand name Kostaive (ARCT-154), is a self-amplifying mRNA COVID-19 vaccine for individuals 18 years and older. … Self-amplification allows for the use of lower doses while providing higher immunogenicity compared to a conventional mRNA COVID-19 vaccine.
IMVT-1402
go.drugbank.com/drugs/DB21979InvestigationalIMVT-1402 is under investigation in clinical trial NCT06754462 (A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid
Dengue virus serotype 1
go.drugbank.com/drugs/DB22664ApprovedDengue virus serotype 1 is a serotype of _Orthoflavivirus denguei_ known to cause dengue fever. … [A274008] It is one of four serotypes covered by Qdenga, a live, attenuated, tetravalent vaccine used for the prevention of dengue disease.
BHV-1300
go.drugbank.com/drugs/DB22673InvestigationalBHV-1300 is a IgG<sub>1,2,4</sub> selective degrader being investigated for the treatment of Grave's disease.
BHV-1310
go.drugbank.com/drugs/DB22674ExperimentalBHV-1310 is a IgG<sub>1,2,4</sub> selective degrader being investigated for the treatment of Grave's disease.